Loading...
FunPep Company Limited
4881.T•JPX
Healthcare
Biotechnology
¥111.00
¥0.00(0.00%)
FunPep Company Limited (4881.T) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for FunPep Company Limited (4881.T), covering cash flow, earnings, and balance sheets.
Revenue Growth
1056.04%
↑ 1056.04%
Operating Income Growth
9.29%
↑ 9.29%
Net Income Growth
4.75%
↑ 4.75%
Operating Cash Flow Growth
45.72%
↑ 45.72%
Operating Margin
-21425.02%
↓ 21425.02%
Gross Margin
-617.93%
↓ 617.93%
Net Profit Margin
-21384.99%
↓ 21384.99%
ROE
-54.28%
↓ 54.28%
ROIC
-57.13%
↓ 57.13%
FunPep Company Limited (4881.T) Income Statement & Financial Overview
View the income breakdown for FunPep Company Limited 4881.T across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $52000.00 | $3.00M | $3.00M | $116000.00 |
| Cost of Revenue | $10.46M | $12.20M | $10.64M | $10.58M |
| Gross Profit | -$10.40M | -$9.58M | -$7.66M | -$10.47M |
| Gross Profit Ratio | -$200.10 | -$3.19 | -$2.55 | -$90.23 |
| R&D Expenses | $502.95M | $216.00M | $98.00M | $127.21M |
| SG&A Expenses | $90.12M | $96.87M | $77.87M | $74.35M |
| Operating Expenses | $593.07M | $312.47M | $176.50M | $201.55M |
| Total Costs & Expenses | $603.53M | $325.00M | $187.00M | $212.14M |
| Interest Income | $1.14M | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $10.46M | $10.25M | $10.64M | $10.00M |
| EBITDA | -$590.07M | -$310.75M | -$171.81M | -$202.02M |
| EBITDA Ratio | -$11347.54 | -$103.58 | -$57.27 | -$1741.58 |
| Operating Income | -$603.48M | -$322.00M | -$184.00M | -$212.02M |
| Operating Income Ratio | -$11605.29 | -$107.33 | -$61.33 | -$1827.76 |
| Other Income/Expenses (Net) | $3.45M | -$10.00M | $2.00M | -$585000.00 |
| Income Before Tax | -$600.03M | -$332.00M | -$182.00M | -$212.60M |
| Income Before Tax Ratio | -$11539.00 | -$110.67 | -$60.67 | -$1832.80 |
| Income Tax Expense | -$1.81M | -$1.71M | -$1.81M | -$1.80M |
| Net Income | -$598.22M | -$330.00M | -$180.00M | -$210.81M |
| Net Income Ratio | -$11504.25 | -$110.00 | -$60.00 | -$1817.28 |
| EPS | -$18.24 | -$10.17 | -$6.36 | -$8.11 |
| Diluted EPS | -$18.24 | -$10.17 | -$6.36 | -$8.11 |
| Weighted Avg Shares Outstanding | $32.79M | $32.41M | $28.29M | $26.009M |
| Weighted Avg Shares Outstanding (Diluted) | $32.79M | $32.41M | $28.29M | $26.009M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan